SNY — Sanofi ADS stock price and chart

SNY

Sanofi ADSStock · Health Care

$42.48-1.53%

as of market close, Sep 18, 2026

☾ AH — —

PeersMRNALLYUNHJNJMRKTMO

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDD

20162019202120242026

38.040.042.044.046.048.050.052.054.056.058.0020.0M40.0M$42.48

2026-09-18

Price$42.48

MA20$44.10

MA50$46.50

Vol10.3M

What would $1,000 invested in SNY be worth today? →

SNY returns: By year · By month · By week · Trailing

Key stats

Price data

Price: $42.48
Change YTD: -12.34%
Next earnings: Oct 30, 2026 · Before open
Market cap: 103.6B2016-09 100.9B2026-09 103.6B+2.7% over the window
Enterprise value: 111.3B
Shares outstanding: 2.4B2015-12 2.6B2025-12 2.4B-7.7% over the window
52W low: $40.89
52W high: $52.68
From 52W high: -19.36%
From 52W low: +3.89%
52W range: 13%
Beta: 0.35

Volume

Rel volume: 0.97×
30D volume: 2.3M
30D $ vol: 101.9M

Fundamentals

EPS (ttm): $3.602015-12 $1.802025-12 $3.60+99.7% over the window
FCF (ttm): 12.2B
FCF/share: $4.99
Book value/share: $34.382015-12 $24.022025-12 $34.38+43.1% over the window
ROE: 10.60%2015-12 7.7%2025-12 10.6%+38.0% over the window
ROA: 5.96%2015-12 4.4%2025-12 6.0%+36.9% over the window
Debt / equity: 0.20×2015-12 0.232025-12 0.20-11.7% over the window
Current ratio: 1.092022-12 1.422025-12 1.09-23.3% over the window

Growth (CAGR, ttm) · 10Y

Net income: +46.17%2024-12-31 → 2025-12-316.1B → 8.9B (+46.1% total)-0.14%2022-12-31 → 2025-12-318.9B → 8.9B (-0.4% total)-8.77%2020-12-31 → 2025-12-3114.1B → 8.9B (-36.8% total)+6.19%2015-12-31 → 2025-12-314.9B → 8.9B (+82.3% total)
Shares: -3.46%2024-12-31 → 2025-12-312.5B → 2.4B (-3.5% total)-1.11%2022-12-31 → 2025-12-312.5B → 2.4B (-3.3% total)-0.51%2020-12-31 → 2025-12-312.5B → 2.4B (-2.5% total)-0.79%2015-12-31 → 2025-12-312.6B → 2.4B (-7.7% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +50.40%2024-12-31 → 2025-12-31$2.40 → $3.60 (+50.4% total)+0.97%2022-12-31 → 2025-12-31$3.50 → $3.60 (+2.9% total)-8.34%2020-12-31 → 2025-12-31$5.57 → $3.60 (-35.3% total)+7.16%2015-12-31 → 2025-12-31$1.80 → $3.60 (+99.7% total)
Book value/share: +7.44%2024-12-31 → 2025-12-31$32.00 → $34.38 (+7.4% total)+2.83%2022-12-31 → 2025-12-31$31.62 → $34.38 (+8.7% total)+2.15%2020-12-31 → 2025-12-31$30.91 → $34.38 (+11.2% total)+3.65%2015-12-31 → 2025-12-31$24.02 → $34.38 (+43.1% total)
Dividend/share: +9.02%2024-12-31 → 2025-12-31$2.03 → $2.22 (+9.0% total)+8.20%2022-12-31 → 2025-12-31$1.75 → $2.22 (+26.7% total)+4.32%2020-12-31 → 2025-12-31$1.80 → $2.22 (+23.5% total)+3.43%2015-12-31 → 2025-12-31$1.58 → $2.22 (+40.2% total)
Price: -10.91%2025-09-18 → 2026-09-18$47.68 → $42.48 (-10.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-7.73%2023-09-18 → 2026-09-18$54.08 → $42.48 (-21.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-2.57%2021-09-17 → 2026-09-18$48.38 → $42.48 (-12.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.01%2016-09-16 → 2026-09-18$38.43 → $42.48 (+10.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -5.97%2025-09-18 → 2026-09-18$45.17 → $42.48 (-6.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-3.36%2023-09-18 → 2026-09-18$47.07 → $42.48 (-9.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+1.72%2021-09-17 → 2026-09-18$39.01 → $42.48 (+8.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+5.23%2016-09-16 → 2026-09-18$25.51 → $42.48 (+66.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 11.8×2016-09 20.702026-09 11.66-43.7% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 14.4×2016-09 16.152026-09 14.43-10.7% over the window
Fwd P/E: 7.9×
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.2×2016-09 1.592026-09 1.24-22.3% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 8.5×
EV/EBITDA (fy): 15.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 11.74%
Dividend yield (fwd)Indicated forward annual dividend ÷ current price — the rate the company has announced, not what was actually paid over the past year.: 5.22%
Dividend/share (fwd): $2.22
Buyback yield (realized, 1y)1 − shares_at(2025-12-31) ÷ shares_at(2024-12-31) = 1 − 2.44B ÷ 2.53B. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 3.46%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (3.46%) + dividends paid over that year ($5.4B) ÷ market_cap_at(2024-12-31) ($121.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 7.89%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($5.5B) ÷ today's market cap ($103.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 5.28%2016-12 2.7%2025-12 4.6%+72.0% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $5.5B + TTM dividends $5.4B) ÷ today's market cap ($103.6B). Same caveat as the cash buyback yield.: 10.50%2016-12 6.6%2025-12 9.2%+39.7% over the window

Vs own 10Y history

P/E: 19th
P/OI: 30th
P/B: 1st

Bar = where today’s multiple sits in SNY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-09-18

-1.53%

-0.68%

-5.54%

+0.24%

YTD

-12.34%

-10.91%

-12.20%

Financial statements

Open full SNY financials →

Loading financial statements…

Ticker	Name	1M	1D
NVS	Novartis AG	-9.18%	-0.39%
NVO	Novo Nordisk A/S	-5.40%	+0.12%
GSK	GSK plc American Depositary Shares (Each representing two Ordinary Shares)	-1.82%	-1.65%
ARGX	argenx SE American Depositary Shares	-0.27%	-0.55%
TAK	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	+4.76%	-0.73%
NTRA	Natera Inc.	+18.51%	+0.84%
TEVA	Teva Pharmaceutical Industries Limited American Depositary Shares	+6.56%	-0.54%
RVMD	Revolution Medicines Inc.	-11.60%	-3.04%

Sanofi ADS (SNY) trades at $42.48 with a live price and an interactive chart covering 24+ years of daily price history, plus key valuation metrics. ChartRow also publishes SNY’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full SNY financial statements →

SNY — Sanofi ADS price, chart and key statistics